子宫内膜癌或宫颈癌门诊机器人辅助子宫切除术可行性与安全性因素
单中心回顾性分析254例子宫内膜癌或宫颈癌患者行机器人子宫切除术,150例(59.1%)住院时间>12小时,104例(40.9%)<12小时。术后呕吐、疼痛控制不佳、手术时间>180分钟、子宫质量>150克、开始时间晚于15:00、VTE史、年龄>75岁、BMI 35-40及术后VTE与>12小时住院相关(p<0.05)。<12小时出院者再入院率未增加(p=0.92)。
要点
- 门诊机器人子宫切除术在子宫内膜癌和宫颈癌中可行且安全,>40%患者12小时内出院且再入院未增加。
- 延长住院(>12小时)的相关因素包括术后呕吐、疼痛控制不佳、手术时间>180分钟等。
- 这些风险因素可用于建立风险分层模型以优化门诊机器人子宫切除术。
核心结论
- 机器人子宫切除术治疗子宫内膜癌和宫颈癌在门诊环境中可行且安全,超过40%患者12小时内出院且再入院率未增加。
- 识别了多个与延长住院相关的因素,为风险分层模型开发提供依据。
研究设计与样本
- 单机构回顾性病历审查,纳入2012至2016年间因宫颈癌或子宫内膜癌行机器人子宫切除术的患者254例。
- 以住院时间(LOS)分为>12小时或<12小时,采用多因素逻辑回归分析相关因素,独立样本t检验比较再入院率。
主要发现
- 254例中150例(59.1%)LOS>12小时,104例(40.9%)LOS<12小时。
- 与LOS>12小时相关的因素(p<0.05)包括:术后呕吐、疼痛控制不佳、手术室时间>180分钟、子宫质量>150克、开始时间晚于15:00、静脉血栓栓塞症(VTE)史、年龄>75岁、体重指数(BMI)35-40及术后VTE形成。
- 12小时内出院者与>12小时出院者再入院率无显著差异(p=0.92)。
临床怎么用
- 对于无上述风险因素的患者,可考虑门诊机器人子宫切除术并在12小时内出院。
- 存在术后呕吐、疼痛控制不佳、手术时间长、子宫质量大、开始时间晚、VTE史、高龄、BMI 35-40等风险因素时,需评估延长住院可能性。
- 门诊机器人子宫切除术不增加再入院风险,可用于合适的子宫内膜癌或宫颈癌患者。
局限性
- 单机构回顾性研究,结果外推需谨慎。
- 样本量有限,可能影响统计效能。
- 未报告其他潜在混杂因素的控制情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Identify factors influencing the feasibility and safety of outpatient robotic-assisted hysterectomy for endometrial or cervical carcinoma. METHODS: A single-institution retrospective chart review of patients who underwent robotic hysterectomy for cervical or endometrial cancer between 2012 and 2016 was performed. Outcomes were measured by length of stay (LOS), which was categorized as an admit-to-discharge time of >12 h or <12 h. Past medical history, surgical history, social history, patient demographics, intraoperative course, and postoperative events were examined as possible factors associated with LOS >12 h. These factors were evaluated using multivariate logistic regression. Readmission rates were compared between the two groups using an independent-samples t-test. RESULTS: Of the 254 patients, 150 (59.1%) had a LOS >12 h and 104 (40.9%) had a LOS < 12 h. The factors associated with a LOS >12 h (p < 0.05) included: Postoperative emesis, inadequate pain control, operating room (OR) time > 180 min, uterine mass > 150 g, start time after 15:00, history of venous thromboembolism (VTE), age > 75 years, body mass index (BMI) 35-40, and post-operative VTE formation. Patients discharged in <12-hours were not more likely than those discharged in >12-hours to be re-admitted (p = 0.92). CONCLUSIONS: Robotic hysterectomy for the treatment of endometrial and cervical carcinoma is both feasible and safe in the outpatient setting, as >40% of patients were successfully discharged within 12 h with no increase in readmission. Multiple risk factors were identified for extended hospitalization, offering potential for the development of a risk stratification model to improve the efficacy of outpatient robotic hysterectomy.
引用
- Matern T, Kang E, Lim PC, et al. Factors in the feasibility and safety of outpatient robotic-assisted hysterectomy for endometrial or cervical carcinoma. Gynecol Oncol. 2020. PMID: 32008793. doi:10.1016/j.ygyno.2020.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。